297 related articles for article (PubMed ID: 17806102)
1. Function of the SIRT1 protein deacetylase in cancer.
Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
[TBL] [Abstract][Full Text] [Related]
2. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J
Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
[TBL] [Abstract][Full Text] [Related]
4. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.
Ford J; Jiang M; Milner J
Cancer Res; 2005 Nov; 65(22):10457-63. PubMed ID: 16288037
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
6. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
7. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A
Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004
[TBL] [Abstract][Full Text] [Related]
8. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
Hida Y; Kubo Y; Murao K; Arase S
Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
[TBL] [Abstract][Full Text] [Related]
9. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
Yan W; Chen X
Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
[TBL] [Abstract][Full Text] [Related]
10. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
11. Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.
Puca R; Nardinocchi L; Starace G; Rechavi G; Sacchi A; Givol D; D'Orazi G
Free Radic Biol Med; 2010 May; 48(10):1338-46. PubMed ID: 20171273
[TBL] [Abstract][Full Text] [Related]
12. Regulation of SIRT1 protein levels by nutrient availability.
Kanfi Y; Peshti V; Gozlan YM; Rathaus M; Gil R; Cohen HY
FEBS Lett; 2008 Jul; 582(16):2417-23. PubMed ID: 18544345
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 is significantly elevated in mouse and human prostate cancer.
Huffman DM; Grizzle WE; Bamman MM; Kim JS; Eltoum IA; Elgavish A; Nagy TR
Cancer Res; 2007 Jul; 67(14):6612-8. PubMed ID: 17638871
[TBL] [Abstract][Full Text] [Related]
14. The critical role of the class III histone deacetylase SIRT1 in cancer.
Liu T; Liu PY; Marshall GM
Cancer Res; 2009 Mar; 69(5):1702-5. PubMed ID: 19244112
[TBL] [Abstract][Full Text] [Related]
15. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells.
Matsushita N; Takami Y; Kimura M; Tachiiri S; Ishiai M; Nakayama T; Takata M
Genes Cells; 2005 Apr; 10(4):321-32. PubMed ID: 15773895
[TBL] [Abstract][Full Text] [Related]
16. Sirtuins and p53.
van Leeuwen I; Lain S
Adv Cancer Res; 2009; 102():171-95. PubMed ID: 19595309
[TBL] [Abstract][Full Text] [Related]
17. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.
Kume S; Haneda M; Kanasaki K; Sugimoto T; Araki S; Isono M; Isshiki K; Uzu T; Kashiwagi A; Koya D
Free Radic Biol Med; 2006 Jun; 40(12):2175-82. PubMed ID: 16785031
[TBL] [Abstract][Full Text] [Related]
18. SirT1 fails to affect p53-mediated biological functions.
Kamel C; Abrol M; Jardine K; He X; McBurney MW
Aging Cell; 2006 Feb; 5(1):81-8. PubMed ID: 16441846
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin inhibitors.
Alcaín FJ; Villalba JM
Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
[TBL] [Abstract][Full Text] [Related]
20. Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription.
Ghosh HS; Spencer JV; Ng B; McBurney MW; Robbins PD
Biochem J; 2007 Nov; 408(1):105-11. PubMed ID: 17680780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
